Are you Dr. Badiozamani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
60 Memorial Medical Pkwy
Palm Coast, FL 32164Phone+1 386-586-2060
Summary
- Dr. Kasra Badiozamani, MD is a radiation oncologist in Palm Coast, Florida. He is currently licensed to practice medicine in Florida, Kansas, and Wisconsin. He is affiliated with AdventHealth Orlando.
Education & Training
University of WashingtonResidency, Radiation Oncology, 1996 - 2000
Duke University HospitalResidency, Radiation Oncology, 1996 - 1996
Spokane Teaching Health CenterInternship, Transitional Year, 1995 - 1996- University of Washington School of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2022 - 2026
WI State Medical License 2021 - 2025
KS State Medical License 2021 - 2022
WA State Medical License 2001 - 2022
WV State Medical License 2020 - 2022
CO State Medical License 2000 - 2003
NC State Medical License 1996 - 1999- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
Publications & Presentations
PubMed
- 4 citationsA prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, wit...Fernando Caumont, Galen Conti, Lauren M. Hurwitz, Claire Kuo, Katherine Levie
Urologic Oncology. 2020-03-03 - 4 citationsGemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?Zaheer Kanji, Alicia M Edwards, Margaret T. Mandelson, Nadav Sahar, Bruce S. Lin
Annals of Surgical Oncology. 2018-01-17 - 15 citationsAdjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621.Mark D. Hurwitz, Jonathan Harris, Oliver Sartor, Ying Xiao, Bobby Shayegan
Cancer. 2017-07-01
